+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pneumonia Therapeutics Market - Global Forecast 2026-2032- Product Image
Pneumonia Therapeutics Market - Global Forecast 2026-2032- Product Image
New

Pneumonia Therapeutics Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 188 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5888889
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The pneumonia therapeutics market is evolving rapidly, driven by clinical complexities, diverse therapeutic innovations, and shifting global healthcare strategies. Senior decision-makers will find actionable insights in this research, designed to clarify key trends, risks, and opportunities in diagnostics, therapies, and commercialization within pneumonia care.

Market Snapshot: Pneumonia Therapeutics Market Overview

The Pneumonia Therapeutics Market grew from USD 18.19 billion in 2025 to USD 19.88 billion in 2026. It is expected to continue growing at a CAGR of 10.59%, reaching USD 36.80 billion by 2032. This expansion reflects heightened demand for advanced anti-infectives, biologic interventions, and supportive care solutions, influenced by rising antimicrobial resistance, demographic changes, and ongoing global health innovation.

Scope & Segmentation

  • Therapy Types: Adjunctive therapies (including corticosteroids and nebulizers), anti-infectives (antibiotics, antifungals, antivirals, with antibiotics grouped as aminoglycosides, beta lactams, macrolides, quinolones, tetracyclines), biologics (immune modulators, monoclonal antibodies), and supportive therapies (fluid management, mechanical ventilation, oxygen therapy).
  • Routes of Administration: Inhalation, intravenous, and oral options, reflecting diverse clinical severity and patient settings.
  • Distribution Channels: Hospital pharmacy, online pharmacy, and retail pharmacy, each addressing acute, home-based, and outpatient access needs.
  • Patient Cohorts: Adult, geriatric, and pediatric groups with unique safety and formulation requirements.
  • Pathogen Classes: Atypical organisms (Chlamydophila, Legionella, Mycoplasma), as well as bacterial, fungal, and viral etiologies, underlining the need for targeted therapies and rapid diagnostics.
  • Indication Types: Community acquired, hospital acquired, and ventilator-associated pneumonia, each requiring evidence-based clinical protocols.
  • Regions: Americas, Europe, Middle East & Africa, Asia-Pacific—regions characterized by varied regulatory, clinical, and manufacturing environments.
[ImageId=GUID1]

Key Takeaways for Senior Leaders

  • Diagnostic advances and precision medicine are redefining pneumonia care pathways, supporting stewardship and payer negotiations through improved outcome tracking.
  • Biologic and host-directed therapies are expanding beyond pathogen eradication, now focusing on modulating inflammation and improving recovery in severe cases.
  • Shifting care models, including telehealth and enhanced inpatient protocols, are changing demand patterns for inpatient and ambulatory pneumonia treatments.
  • Antimicrobial resistance remains a critical driver, influencing investment in novel drug classes and adjunctive approaches to strengthen current treatment options.
  • Differentiated product design—such as inhalation formulations and step-down oral therapies—is influencing adherence, dosing, and positioning across settings and patient age groups.
  • Real-world evidence of total-cost-of-care benefits is increasingly essential for competitive differentiation with payers and health systems.
[ImageId=GUID2]

Tariff Impact on Supply and Strategy

Recent United States tariff changes affect input costs for active pharmaceutical ingredients, inhalation devices, and ventilator-related components. These factors are prompting manufacturers to reassess sourcing, inventory management, and possible onshore production to ensure cost control and supply continuity. Hospitals and distributors are extending contract terms, intensifying tendering, and increasing safety stocks. Manufacturers are also innovating with alternative packaging and device designs to minimize tariff exposure, offering new opportunities for operational resilience and product portfolio diversification.

Regional Dynamics in Adoption and Access

Regional differences influence clinical practice, regulatory processes, and commercialization approaches:

  • The Americas emphasize outcome-based purchasing, antimicrobial stewardship, and value-focused reimbursement.
  • Europe, Middle East & Africa exhibit varied regulatory timelines and infrastructure, driving disparate adoption curves for biologics and integrated therapies.
  • Asia-Pacific markets pair rapid innovation adoption with support for local manufacturing and expedited approvals, expediting supply and access to high-burden populations.

Pneumonia Therapeutics Market: Methodology & Data Sources

This analysis leverages peer-reviewed clinical literature, regulatory documents, and market reports, supported by interviews with clinicians, supply chain experts, and commercial leaders. Multiple independent sources were triangulated to validate trends, and transparency in evidence selection was maintained throughout. Emphasis was placed on practical insights relevant to both acute and outpatient settings.

Why This Report Matters

  • Enables alignment of R&D, supply resilience, and diagnostics partnerships with evolving payer and provider requirements.
  • Offers clarity on regulatory, regional, and supply chain dynamics for more informed market-entry and expansion strategies.
  • Supports product development that meets clinical differentiation and system-level value imperatives.
[ImageId=GUID3]

Conclusion

The pneumonia therapeutics sector is undergoing significant transformation, requiring integrated approaches across development, operations, and market access. Firms prioritizing adaptable, evidence-driven strategies will better position themselves for long-term success and sustainable adoption in a dynamic global environment.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Pneumonia Therapeutics Market, by Therapy Type
8.1. Adjunctive Therapies
8.1.1. Corticosteroids
8.1.2. Nebulizers
8.2. Anti Infectives
8.2.1. Antibiotics
8.2.1.1. Aminoglycosides
8.2.1.2. Beta Lactams
8.2.1.3. Macrolides
8.2.1.4. Quinolones
8.2.1.5. Tetracyclines
8.2.2. Antifungals
8.2.3. Antivirals
8.3. Biologics
8.3.1. Immune Modulators
8.3.2. Monoclonal Antibodies
8.4. Supportive Therapies
8.4.1. Fluid Management
8.4.2. Mechanical Ventilation
8.4.3. Oxygen Therapy
9. Pneumonia Therapeutics Market, by Route Of Administration
9.1. Inhalation
9.2. Intravenous
9.3. Oral
10. Pneumonia Therapeutics Market, by Patient Age Group
10.1. Adult
10.2. Geriatric
10.3. Pediatric
11. Pneumonia Therapeutics Market, by Pathogen Type
11.1. Atypical
11.1.1. Chlamydophila
11.1.2. Legionella
11.1.3. Mycoplasma
11.2. Bacterial
11.3. Fungal
11.4. Viral
12. Pneumonia Therapeutics Market, by Distribution Channel
12.1. Hospital Pharmacy
12.2. Online Pharmacy
12.3. Retail Pharmacy
13. Pneumonia Therapeutics Market, by Indication Type
13.1. Community Acquired
13.2. Hospital Acquired
13.3. Ventilator Associated
14. Pneumonia Therapeutics Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Pneumonia Therapeutics Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Pneumonia Therapeutics Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Pneumonia Therapeutics Market
18. China Pneumonia Therapeutics Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. Abbott Laboratories
19.6. Allergan plc
19.7. AstraZeneca PLC
19.8. Aurobindo Pharma Limited
19.9. Bayer AG
19.10. Biobrick Pharma
19.11. Cipla Limited
19.12. Dr. Reddy's Laboratories Ltd.
19.13. Eli Lilly and Company
19.14. F. Hoffmann-La Roche Ltd.
19.15. GlaxoSmithKline PLC
19.16. Hikma Pharmaceuticals PLC
19.17. Lincoln Pharmaceuticals Ltd.
19.18. Lupin Pharmaceuticals, Inc.
19.19. Mankind Pharma Ltd.
19.20. Merck & Co., Inc.
19.21. Novartis AG
19.22. Pfizer Inc.
19.23. Sanofi S.A.
19.24. Seqirus UK Limited by CSL Limited
19.25. Serum Institute of India
19.26. Sun Pharmaceutical Industries Ltd.
19.27. Teva Pharmaceutical Industries Ltd.
19.28. Viatris Inc.
19.29. Wellona Pharma
19.30. Zydus Healthcare Limited
List of Figures
FIGURE 1. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL PNEUMONIA THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL PNEUMONIA THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY PATHOGEN TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY INDICATION TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES PNEUMONIA THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA PNEUMONIA THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY ADJUNCTIVE THERAPIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY ADJUNCTIVE THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY ADJUNCTIVE THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY ADJUNCTIVE THERAPIES, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY CORTICOSTEROIDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY CORTICOSTEROIDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY NEBULIZERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY NEBULIZERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY NEBULIZERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY ANTI INFECTIVES, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY ANTI INFECTIVES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY ANTI INFECTIVES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY AMINOGLYCOSIDES, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY AMINOGLYCOSIDES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY AMINOGLYCOSIDES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY BETA LACTAMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY BETA LACTAMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY BETA LACTAMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY MACROLIDES, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY MACROLIDES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY MACROLIDES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY QUINOLONES, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY QUINOLONES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY QUINOLONES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY TETRACYCLINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY TETRACYCLINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY TETRACYCLINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY ANTIFUNGALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY ANTIFUNGALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY ANTIFUNGALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY ANTIVIRALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY ANTIVIRALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY ANTIVIRALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY BIOLOGICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY BIOLOGICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY IMMUNE MODULATORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY IMMUNE MODULATORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY IMMUNE MODULATORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY SUPPORTIVE THERAPIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY SUPPORTIVE THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY SUPPORTIVE THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY SUPPORTIVE THERAPIES, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY FLUID MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY FLUID MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY FLUID MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY MECHANICAL VENTILATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY MECHANICAL VENTILATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY MECHANICAL VENTILATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY OXYGEN THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY OXYGEN THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY OXYGEN THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY INHALATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY INHALATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY INHALATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY ATYPICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY ATYPICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY ATYPICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY ATYPICAL, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY CHLAMYDOPHILA, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY CHLAMYDOPHILA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY CHLAMYDOPHILA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY LEGIONELLA, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY LEGIONELLA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY LEGIONELLA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY MYCOPLASMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY MYCOPLASMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY MYCOPLASMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY BACTERIAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY BACTERIAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY FUNGAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY FUNGAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY FUNGAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY VIRAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY VIRAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY VIRAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY COMMUNITY ACQUIRED, BY REGION, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY COMMUNITY ACQUIRED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY COMMUNITY ACQUIRED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY HOSPITAL ACQUIRED, BY REGION, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY HOSPITAL ACQUIRED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY HOSPITAL ACQUIRED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY VENTILATOR ASSOCIATED, BY REGION, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY VENTILATOR ASSOCIATED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY VENTILATOR ASSOCIATED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 129. AMERICAS PNEUMONIA THERAPEUTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 130. AMERICAS PNEUMONIA THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 131. AMERICAS PNEUMONIA THERAPEUTICS MARKET SIZE, BY ADJUNCTIVE THERAPIES, 2018-2032 (USD MILLION)
TABLE 132. AMERICAS PNEUMONIA THERAPEUTICS MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
TABLE 133. AMERICAS PNEUMONIA THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 134. AMERICAS PNEUMONIA THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 135. AMERICAS PNEUMONIA THERAPEUTICS MARKET SIZE, BY SUPPORTIVE THERAPIES, 2018-2032 (USD MILLION)
TABLE 136. AMERICAS PNEUMONIA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 137. AMERICAS PNEUMONIA THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 138. AMERICAS PNEUMONIA THERAPEUTICS MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
TABLE 139. AMERICAS PNEUMONIA THERAPEUTICS MARKET SIZE, BY ATYPICAL, 2018-2032 (USD MILLION)
TABLE 140. AMERICAS PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 141. AMERICAS PNEUMONIA THERAPEUTICS MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
TABLE 142. NORTH AMERICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 143. NORTH AMERICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 144. NORTH AMERICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY ADJUNCTIVE THERAPIES, 2018-2032 (USD MILLION)
TABLE 145. NORTH AMERICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
TABLE 146. NORTH AMERICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 147. NORTH AMERICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 148. NORTH AMERICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY SUPPORTIVE THERAPIES, 2018-2032 (USD MILLION)
TABLE 149. NORTH AMERICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 150. NORTH AMERICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 151. NORTH AMERICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
TABLE 152. NORTH AMERICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY ATYPICAL, 2018-2032 (USD MILLION)
TABLE 153. NORTH AMERICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 154. NORTH AMERICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
TABLE 155. LATIN AMERICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 156. LATIN AMERICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 157. LATIN AMERICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY ADJUNCTIVE THERAPIES, 2018-2032 (USD MILLION)
TABLE 158. LATIN AMERICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
TABLE 159. LATIN AMERICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 160. LATIN AMERICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 161. LATIN AMERICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY SUPPORTIVE THERAPIES, 2018-2032 (USD MILLION)
TABLE 162. LATIN AMERICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 163. LATIN AMERICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 164. LATIN AMERICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
TABLE 165. LATIN AMERICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY ATYPICAL, 2018-2032 (USD MILLION)
TABLE 166. LATIN AMERICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 167. LATIN AMERICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY ADJUNCTIVE THERAPIES, 2018-2032 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY SUPPORTIVE THERAPIES, 2018-2032 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY ATYPICAL, 2018-2032 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
TABLE 181. EUROPE PNEUMONIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 182. EUROPE PNEUMONIA THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 183. EUROPE PNEUMONIA THERAPEUTICS MARKET SIZE, BY ADJUNCTIVE THERAPIES, 2018-2032 (USD MILLION)
TABLE 184. EUROPE PNEUMONIA THERAPEUTICS MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
TABLE 185. EUROPE PNEUMONIA THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 186. EUROPE PNEUMONIA THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 187. EUROPE PNEUMONIA THERAPEUTICS MARKET SIZE, BY SUPPORTIVE THERAPIES, 2018-2032 (USD MILLION)
TABLE 188. EUROPE PNEUMONIA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 189. EUROPE PNEUMONIA THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 190. EUROPE PNEUMONIA THERAPEUTICS MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
TABLE 191. EUROPE PNEUMONIA THERAPEUTICS MARKET SIZE, BY ATYPICAL, 2018-2032 (USD MILLION)
TABLE 192. EUROPE PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 193. EUROPE PNEUMONIA THERAPEUTICS MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
TABLE 194. MIDDLE EAST PNEUMONIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 195. MIDDLE EAST PNEUMONIA THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 196. MIDDLE EAST PNEUMONIA THERAPEUTICS MARKET SIZE, BY ADJUNCTIVE THERAPIES, 2018-2032 (USD MILLION)
TABLE 197. MIDDLE EAST PNEUMONIA THERAPEUTICS MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
TABLE 198. MIDDLE EAST PNEUMONIA THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 199. MIDDLE EAST PNEUMONIA THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 200. MIDDLE EAST PNEUMONIA THERAPEUTICS MARKET SIZE, BY SUPPORTIVE THERAPIES, 2018-2032 (USD MILLION)
TABLE 201. MIDDLE EAST PNEUMONIA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 202. MIDDLE EAST PNEUMONIA THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 203. MIDDLE EAST PNEUMONIA THERAPEUTICS MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
TABLE 204. MIDDLE EAST PNEUMONIA THERAPEUTICS MARKET SIZE, BY ATYPICAL, 2018-2032 (USD MILLION)
TABLE 205. MIDDLE EAST PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 206. MIDDLE EAST PNEUMONIA THERAPEUTICS MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
TABLE 207. AFRICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 208. AFRICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 209. AFRICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY ADJUNCTIVE THERAPIES, 2018-2032 (USD MILLION)
TABLE 210. AFRICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
TABLE 211. AFRICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 212. AFRICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 213. AFRICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY SUPPORTIVE THERAPIES, 2018-2032 (USD MILLION)
TABLE 214. AFRICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 215. AFRICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 216. AFRICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
TABLE 217. AFRICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY ATYPICAL, 2018-2032 (USD MILLION)
TABLE 218. AFRICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 219. AFRICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
TABLE 220. ASIA-PACIFIC PNEUMONIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 221. ASIA-PACIFIC PNEUMONIA THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 222. ASIA-PACIFIC PNEUMONIA THERAPEUTICS MARKET SIZE, BY ADJUNCTIVE THERAPIES, 2018-2032 (USD MILLION)
TABLE 223. ASIA-PACIFIC PNEUMONIA THERAPEUTICS MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
TABLE 224. ASIA-PACIFIC PNEUMONIA THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 225. ASIA-PACIFIC PNEUMONIA THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 226. ASIA-PACIFIC PNEUMONIA THERAPEUTICS MARKET SIZE, BY SUPPORTIVE THERAPIES, 2018-2032 (USD MILLION)
TABLE 227. ASIA-PACIFIC PNEUMONIA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 228. ASIA-PACIFIC PNEUMONIA THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 229. ASIA-PACIFIC PNEUMONIA THERAPEUTICS MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
TABLE 230. ASIA-PACIFIC PNEUMONIA THERAPEUTICS MARKET SIZE, BY ATYPICAL, 2018-2032 (USD MILLION)
TABLE 231. ASIA-PACIFIC PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 232. ASIA-PACIFIC PNEUMONIA THERAPEUTICS MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
TABLE 233. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 234. ASEAN PNEUMONIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 235. ASEAN PNEUMONIA THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 236. ASEAN PNEUMONIA THERAPEUTICS MARKET SIZE, BY ADJUNCTIVE THERAPIES, 2018-2032 (USD MILLION)
TABLE 237. ASEAN PNEUMONIA THERAPEUTICS MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
TABLE 238. ASEAN PNEUMONIA THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 239. ASEAN PNEUMONIA THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 240. ASEAN PNEUMONIA THERAPEUTICS MARKET SIZE, BY SUPPORTIVE THERAPIES, 2018-2032 (USD MILLION)
TABLE 241. ASEAN PNEUMONIA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 242. ASEAN PNEUMONIA THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 243. ASEAN PNEUMONIA THERAPEUTICS MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
TABLE 244. ASEAN PNEUMONIA THERAPEUTICS MARKET SIZE, BY ATYPICAL, 2018-2032 (USD MILLION)
TABLE 245. ASEAN PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 246. ASEAN PNEUMONIA THERAPEUTICS MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
TABLE 247. GCC PNEUMONIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 248. GCC PNEUMONIA THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 249. GCC PNEUMONIA THERAPEUTICS MARKET SIZE, BY ADJUNCTIVE THERAPIES, 2018-2032 (USD MILLION)
TABLE 250. GCC PNEUMONIA THERAPEUTICS MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
TABLE 251. GCC PNEUMONIA THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 252. GCC PNEUMONIA THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 253. GCC PNEUMONIA THERAPEUTICS MARKET SIZE, BY SUPPORTIVE THERAPIES, 2018-2032 (USD MILLION)
TABLE 254. GCC PNEUMONIA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 255. GCC PNEUMONIA THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 256. GCC PNEUMONIA THERAPEUTICS MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
TABLE 257. GCC PNEUMONIA THERAPEUTICS MARKET SIZE, BY ATYPICAL, 2018-2032 (USD MILLION)
TABLE 258. GCC PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 259. GCC PNEUMONIA THERAPEUTICS MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
TABLE 260. EUROPEAN UNION PNEUMONIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 261. EUROPEAN UNION PNEUMONIA THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 262. EUROPEAN UNION PNEUMONIA THERAPEUTICS MARKET SIZE, BY ADJUNCTIVE THERAPIES, 2018-2032 (USD MILLION)
TABLE 263. EUROPEAN UNION PNEUMONIA THERAPEUTICS MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
TABLE 264. EUROPEAN UNION PNEUMONIA THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 265. EUROPEAN UNION PNEUMONIA THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 266. EUROPEAN UNION PNEUMONIA THERAPEUTICS MARKET SIZE, BY SUPPORTIVE THERAPIES, 2018-2032 (USD MILLION)
TABLE 267. EUROPEAN UNION PNEUMONIA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 268. EUROPEAN UNION PNEUMONIA THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 269. EUROPEAN UNION PNEUMONIA THERAPEUTICS MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
TABLE 270. EUROPEAN UNION PNEUMONIA THERAPEUTICS MARKET SIZE, BY ATYPICAL, 2018-2032 (USD MILLION)
TABLE 271. EUROPEAN UNION PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 272. EUROPEAN UNION PNEUMONIA THERAPEUTICS MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
TABLE 273. BRICS PNEUMONIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 274. BRICS PNEUMONIA THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 275. BRICS PNEUMONIA THERAPEUTICS MARKET SIZE, BY ADJUNCTIVE THERAPIES, 2018-2032 (USD MILLION)
TABLE 276. BRICS PNEUMONIA THERAPEUTICS MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
TABLE 277. BRICS PNEUMONIA THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 278. BRICS PNEUMONIA THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 279. BRICS PNEUMONIA THERAPEUTICS MARKET SIZE, BY SUPPORTIVE THERAPIES, 2018-2032 (USD MILLION)
TABLE 280. BRICS PNEUMONIA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 281. BRICS PNEUMONIA THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 282. BRICS PNEUMONIA THERAPEUTICS MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
TABLE 283. BRICS PNEUMONIA THERAPEUTICS MARKET SIZE, BY ATYPICAL, 2018-2032 (USD MILLION)
TABLE 284. BRICS PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 285. BRICS PNEUMONIA THERAPEUTICS MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
TABLE 286. G7 PNEUMONIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 287. G7 PNEUMONIA THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 288. G7 PNEUMONIA THERAPEUTICS MARKET SIZE, BY ADJUNCTIVE THERAPIES, 2018-2032 (USD MILLION)
TABLE 289. G7 PNEUMONIA THERAPEUTICS MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
TABLE 290. G7 PNEUMONIA THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 291. G7 PNEUMONIA THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 292. G7 PNEUMONIA THERAPEUTICS MARKET SIZE, BY SUPPORTIVE THERAPIES, 2018-2032 (USD MILLION)
TABLE 293. G7 PNEUMONIA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 294. G7 PNEUMONIA THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 295. G7 PNEUMONIA THERAPEUTICS MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
TABLE 296. G7 PNEUMONIA THERAPEUTICS MARKET SIZE, BY ATYPICAL, 2018-2032 (USD MILLION)
TABLE 297. G7 PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 298. G7 PNEUMONIA THERAPEUTICS MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
TABLE 299. NATO PNEUMONIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 300. NATO PNEUMONIA THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 301. NATO PNEUMONIA THERAPEUTICS MARKET SIZE, BY ADJUNCTIVE THERAPIES, 2018-2032 (USD MILLION)
TABLE 302. NATO PNEUMONIA THERAPEUTICS MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
TABLE 303. NATO PNEUMONIA THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 304. NATO PNEUMONIA THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 305. NATO PNEUMONIA THERAPEUTICS MARKET SIZE, BY SUPPORTIVE THERAPIES, 2018-2032 (USD MILLION)
TABLE 306. NATO PNEUMONIA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 307. NATO PNEUMONIA THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 308. NATO PNEUMONIA THERAPEUTICS MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
TABLE 309. NATO PNEUMONIA THERAPEUTICS MARKET SIZE, BY ATYPICAL, 2018-2032 (USD MILLION)
TABLE 310. NATO PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 311. NATO PNEUMONIA THERAPEUTICS MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
TABLE 312. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 313. UNITED STATES PNEUMONIA THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 314. UNITED STATES PNEUMONIA THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 315. UNITED STATES PNEUMONIA THERAPEUTICS MARKET SIZE, BY ADJUNCTIVE THERAPIES, 2018-2032 (USD MILLION)
TABLE 316. UNITED STATES PNEUMONIA THERAPEUTICS MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
TABLE 317. UNITED STATES PNEUMONIA THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 318. UNITED STATES PNEUMONIA THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 319. UNITED STATES PNEUMONIA THERAPEUTICS MARKET SIZE, BY SUPPORTIVE THERAPIES, 2018-2032 (USD MILLION)
TABLE 320. UNITED STATES PNEUMONIA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD

Companies Mentioned

The key companies profiled in this Pneumonia Therapeutics market report include:
  • Abbott Laboratories
  • Allergan plc
  • AstraZeneca PLC
  • Aurobindo Pharma Limited
  • Bayer AG
  • Biobrick Pharma
  • Cipla Limited
  • Dr. Reddy's Laboratories Ltd.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline PLC
  • Hikma Pharmaceuticals PLC
  • Lincoln Pharmaceuticals Ltd.
  • Lupin Pharmaceuticals, Inc.
  • Mankind Pharma Ltd.
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A.
  • Seqirus UK Limited by CSL Limited
  • Serum Institute of India
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Wellona Pharma
  • Zydus Healthcare Limited

Table Information

Report AttributeDetails
No. of Pages188
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 19.88 Billion
Forecasted Market Value ( USD ) by 2032 $ 36.8 Billion
Compound Annual Growth Rate10.5%
Regions CoveredGlobal
No. of Companies Mentioned27

Related Topics

Related Reports

Pneumonia Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2025-2033 - Product Image

Pneumonia Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2025-2033

  • Report
  • 181 Pages
  • Global
From
Bacterial Pneumonia Drug Pipeline Analysis Report 2025 - Product Image

Bacterial Pneumonia Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • 200 Pages
  • Global
From
Pneumonia Therapeutics - Global Strategic Business Report - Product Image

Pneumonia Therapeutics - Global Strategic Business Report

  • Report
  • 100 Pages
  • Global
From
Pneumonia Therapeutics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Pneumonia Therapeutics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 138 Pages
  • Global
From
Community-acquired Pneumonia (CAP) - Pipeline Insight, 2025 - Product Image

Community-acquired Pneumonia (CAP) - Pipeline Insight, 2025

  • Clinical Trials
  • 60 Pages
  • Global
From

About the Pneumonia Drug Market

The Pneumonia Drug market is a subset of the larger Respiratory Drugs market. It includes drugs used to treat bacterial, viral, and fungal pneumonia, as well as other respiratory infections. These drugs are typically administered orally, intravenously, or intramuscularly, depending on the severity of the infection. Commonly prescribed drugs include antibiotics, antivirals, antifungals, and corticosteroids. In addition, some drugs are used to reduce inflammation and improve breathing. The Pneumonia Drug market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck, Sanofi, AstraZeneca, and Novartis. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.